| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-1411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-141 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09 |
| filingDate |
2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb2bcc0e153d3efeadcc9840b3ce2ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f184f9de6899c74f2a59b41a589eac63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b83725cd04bc30b0e22e2dd04b3c4ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a745a6022c7cf417ee29b809163a89e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c71d7b7a7919c25809c8aa83c8234cfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9565cd8517f4cf1e344d6068d1238807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa79edaa42e3b6850a72eeb01dda6e9 |
| publicationDate |
2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010197951-A1 |
| titleOfInvention |
Compounds for preparing immunological adjuvant |
| abstract |
The present invention provides methods for preparing TLR-4 receptor agonist E6020: n n n n n n n n n n and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates useful for implementing the inventive methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8519170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8754236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012042003-A1 |
| priorityDate |
2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |